ArticleThe Journal of biological chemistry2026

Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential.

Rachel M Golonka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.